Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Dec;1(2):78-87.
doi: 10.1258/om.2008.080014. Epub 2008 Dec 1.

Contraception in women with medical problems

Mandish K Dhanjal  1
Affiliations
Review

Contraception in women with medical problems

Mandish K Dhanjal. Obstet Med. 2008 Dec.

Abstract

Women with medical disease have a higher incidence of maternal mortality compared with healthy women, with cardiac disease now being the most common cause of maternal death in the UK. A handful of medical conditions exist where pregnancy is not recommended due to mortality rates approaching 50%. It is imperative that such women have the most reliable methods of contraception available. Contraceptive agents may themselves affect medical disease, or may interact with medications used by such women. There may be a range of contraceptive agents suitable for each medical condition. The contraceptive selected should be tailored to suit the individual. The following points should be considered when deciding on the most appropriate contraceptive agent: efficacy, thrombotic risk (oestrogen containing contraceptives), arterial risks (oestrogen containing contraceptives), infective risk (e.g. insertion of intrauterine device [IUD]), vagal stimulation (e.g. insertion of IUD, ESSURE(®)), bleeding risks with patients on anticoagulants, interaction with concomitant drugs, effects of anaesthesia and ease of use. This review aims to cover the different contraceptive agents available and the best ones to use for certain medical illnesses.

Keywords: contraception; general medicine; high-risk pregnancy.

PubMed Disclaimer

References

    1. Lewis G, ed. The Confidential Enquiry into Maternal and Child Health (CEMACH) Saving Mothers' Lives: Reviewing Maternal Deaths to make Motherhood Safer 2003–5. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007. See: http://www.cemach.org.uk/Publications/CEMACH-Publications/Maternal-and-P... (last accessed 5 March 2008)
    1. WHO. Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use. 3rd edn Geneva: Reproductive Health and Research, World Health Organization, 2004. See: http://www.who.int/reproductive-health/publications/index.htm (last accessed 5 March 2008)
    1. Office for National Statistics and Teenage Pregnancy Unit, February. 2008 See: http://www.everychildmatters.gov.uk/_files/6D17854AF93522B6D2C32EE0A954A.... (last accessed 5 March 2008)
    1. Peterson HB, Xia Z, Hughes JM, et al. The risk of pregnancy after tubal sterilization: findings from the US collaborative review of sterilization. Am J Obstet Gynecol 1196;174:1161–70 - PubMed
    1. Royal College of Obstetricians and Gynaecologists. Male and Female Sterilisation. Evidence-based Clinical Guidelines No. 4. London: RCOG Press, 2003.